腹腔镜与机器人子宫肌瘤剔除术的手术及术后结局:系统综述与Meta分析
该系统综述与Meta分析检索了PubMed、EMBASE和Scopus,纳入18项研究共2266例有症状子宫肌瘤患者,比较机器人 vs 腹腔镜子宫肌瘤剔除术。机器人组失血量显著更少(MD 36.35 mL,95%CI 0.53-72.18),中转开腹率更低(RR 0.47,95%CI 0.29-0.78);输血率、术后并发症及术后发热无显著差异。
要点
- 机器人子宫肌瘤剔除术失血量较腹腔镜显著减少(MD 36.35 mL)。
- 机器人组中转开腹风险显著低于腹腔镜组(RR 0.47)。
- 两种术式在输血率、术后并发症及术后发热方面无显著差异。
核心结论
- 机器人子宫肌瘤剔除术在减少失血量和降低中转开腹率方面优于腹腔镜。
- 两种术式在输血率、术后并发症及术后发热方面无显著差异,均具安全性。
- 术式选择可结合患者特征与资源可用性进行决策。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、EMBASE和Scopus(2025年10月至11月,无日期限制)。
- 初检获398篇文献,最终纳入18项回顾性、前瞻性或非随机临床研究。
- 共分析2266例患者,其中腹腔镜组1199例,机器人组1067例。
主要发现
- 机器人组失血量显著低于腹腔镜组(MD 36.35 mL;95%CI 0.53-72.18)。
- 机器人组中转开腹率显著低于腹腔镜组(RR 0.47;95%CI 0.29-0.78)。
- 输血率无显著差异(RR 1.03;95%CI 0.76-1.70)。
- 术后并发症无显著差异(RR 1.06;95%CI 0.67-1.59)。
- 术后发热无显著差异(RR 0.55;95%CI 0.13-2.33)。
临床怎么用
- 对于有症状子宫肌瘤患者,机器人或腹腔镜子宫肌瘤剔除术均可作为安全选择。
- 当需减少失血或降低中转开腹风险时,可优先考虑机器人手术。
- 最终术式需结合患者具体特征及医疗资源条件个体化决定。
局限性
- 纳入研究为回顾性、前瞻性或非随机设计,可能存在选择偏倚。
- 未报告随机对照试验数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare surgical and postoperative outcomes associated with robotic and laparoscopic myomectomy in women with symptomatic uterine leiomyomas and to inform clinical decision-making. DATA SOURCES: From October to November 2025, a comprehensive search was conducted in PubMed, EMBASE, and Scopus with no date restrictions. The search strategy included the following terms: "Leiomyoma" OR "Uterus myoma" OR "Fibroids" AND "Robotic surgical procedures" OR "Robotic assisted surgery" AND "Laparoscopy" OR "Uterine myomectomy" AND "Postoperative complications." METHODS OF STUDY SELECTION: The initial search yielded 398 articles. After duplicate removal and application of selection criteria, 18 studies were included in the systematic review. Retrospective, prospective and non-randomized clinical studies evaluating clinical outcomes in women with symptomatic uterine leiomyomas undergoing robotic or laparoscopic myomectomy were included. TABULATION, INTEGRATION, AND RESULTS: A total of 2266 patients were analyzed (1199 underwent laparoscopic myomectomy and 1067 robotic myomectomy). Robotic myomectomy was associated with significantly lower blood loss (MD 36.35 mL; 95% CI 0.53-72.18) and lower conversion rates to laparotomy (relative risk [RR] 0.47 ; 95% CI: CI: 0.29-0.78) compared with laparoscopy. No significant differences were observed in transfusion rates (RR 1.03; 95% CI 0.76-1.70), postoperative complications (RR 1.06; 95% CI 0.67-1.59), or postoperative fever (RR 0.55; 95% CI 0.13-2.33). CONCLUSION: Robotic myomectomy demonstrated advantages over laparoscopy in terms of reduced blood loss and lower conversion rates to laparotomy. Other outcomes presented no significant differences between the two techniques. These findings support the safety of both approaches and may guide surgical decision-making based on patient characteristics and resource availability.
引用
- Marucci da Silva GF, da Silva LBB, de Andrade Reis ML, et al. Surgical and Postoperative Outcomes in Laparoscopic vs Robotic Myomectomy: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2026. PMID: 42498219. doi:10.1016/j.jmig.2026.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。